Cargando…
Bisphosphonate-associated osteonecrosis of the jaw: the rheumatologist's role
Several recent reports have described osteonecrosis of the jaws (ONJ) associated with the use of bisphosphonates. Rheumatologists treating bone diseases with bisphosphonate need, therefore, to be aware of this potential risk and plan the prophylaxis, early diagnosis and prevention of potential conse...
Autores principales: | , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1779450/ https://www.ncbi.nlm.nih.gov/pubmed/17049069 http://dx.doi.org/10.1186/ar2050 |